We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Suturless Method Joins Blood Vessels End-to-End

By HospiMedica International staff writers
Posted on 08 Sep 2011
A new study describes a novel procedure that uses a poloxamer gel and a bioadhesive to join blood vessels in vascular anastomosis. More...


Researchers at the Stanford University School of Medicine (CA, USA), led by microsurgeon Geoffrey Gurtner, MD, developed the new method of suturless and atraumatic vascular anastomosis based on the properties of a thermo-reversible tri-block poloxamer; the poloxamer becomes solid and elastic when heated above body temperature, but dissolve harmlessly into the bloodstream when cooled. The poloxamer is heated using used a simple halogen lamp, thus distending both openings of a severed blood vessel, allowing the researchers to glue them together precisely using Dermabond, a surgical sealant made by Ethicon (Somerville, NJ, USA).

Using this technique, the researchers were able to perform end-to-end anastomoses five times more rapidly than hand-sewn controls, and vessels that were too small (less than one mm) to sew were successfully reconstructed with the suturless approach. Subsequent imaging of a reconstructed rat aorta confirmed equivalent patency, flow, and burst strength, and histological analysis demonstrated decreased inflammation and fibrosis at up to two years after the procedure. The study was published early online on August 28, 2011, in Nature Medicine.

“When you're bringing together hollow tubes, whether they're large structures, like the colon or the aorta, or a small structure, like a vein in the finger of a child, you're always worried about lining them up directly and effectively sealing them,” said study coauthor Michael Longaker, MD. “The technique that Dr. Gurtner has pioneered could allow surgeons to perform anastomosis more quickly and with improved precision. Coming up with this solution was the result of the classic Stanford model of bringing together researchers from a variety of disciplines.”

A poloxamer is a synthetic block copolymer of ethylene oxide and propylene oxide. They are often used as surfactants, emulsifiers, stabilizers, and food additives.

Related Links:
Stanford University School of Medicine
Ethicon



Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Hemostatic Agent
HEMOBLAST Bellows
Bipolar Coagulation Generator
Aesculap
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.